Commandez votre montre hebdomadaire Deciphera Pharmaceuticals, LLC
Quantité totale PI	246
Rang # Quantité totale PI	5 463
Note d'activité PI	3,2/5.0    255
Rang # Activité PI	2 779
Classe Nice dominante	Produits pharmaceutiques, vétéri...

Brevets Marques 105 16 29 9 69 5 13
Dernier brevet	2026 - Solid state forms of a kinase in...
Premier brevet	2003 - Anti-cancer medicaments
Dernière marque	2026 - Romvimza
Première marque	2019 - QINLOCK

Industrie (Classification de Nice)

Derniers inventions, produits et services 2026 P/S Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), gi... 2025 Invention Solid state forms of a kinase inhibitor. Described herein, in part, are solid-state forms of the ... Invention Csf-1r inhibitors and methods of use thereof. Provided herein, in part, is a compound of Formula... Invention Methods of treating disorders using csfir inhibitors. Described herein are methods of treating ca... Invention Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof. Described herei... Invention Solid state forms of a ulk inhibitor. Provided herein, in part, are solid-state salt forms of the... Invention Solid state forms of ulk inhibitors. Provided herein, in part, are solid-state forms of the compo... Invention Amorphous kinase inhibitor formulations and methods of use thereof. Provided herein is an amorph... Invention Solid state forms of ripretinib. The present disclosure relates to solid state forms of ripretin... Invention Processes of making csf-1r inhibitors and methods of use thereof. The present disclosure relates ... Invention Csf-1r inhibitors and methods of use thereof. Provided herein, in part, is a compound of Formula ... Invention Formulations of vimseltinib. Described herein, in part, are pharmaceutically acceptable formulati... P/S Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, sy... P/S downloadable mobile application for use by patients to manage, track, and generate reports on med... P/S Provision of consumer information regarding the selection of prescription medications to be purch... Invention Aminopyrimidine amide autophagy inhibitors and methods of use thereof. Described herein are comp... Invention Methods of treating gastrointestinal stromal tumors. The present disclosure relates to methods o... Invention Methods of treating tenosynovial giant cell tumors. The present disclosure provides, inter alia,... Invention Methods of treating disorders using csf1r inhibitors. Described herein are methods of treating ca... Invention Ulk inhibitors and methods of use thereof. Described herein are compounds of formula (I) that are... P/S Pharmaceutical preparations and biological materials for treating tenosynovial giant cell tumor (... 2024 Invention Raf kinase inhibitors and methods of use thereof. Described herein are compounds that are RAF in... Invention Dual raf and tubulin inhibitors and methods of use thereof. Described herein are compounds that ... Invention Dual raf and tubulin inhibitors and methods of use thereof. Described herein are compounds of for... Invention Vps34 inhibitors and methods of use thereof. The present disclosure, in part, provide compounds ... Invention Vps34 inhibitors and methods of use thereof. The present disclosure, in part, provide compounds o... Invention Formulations of a csf-1r inhibitor. Described herein, in part, are pharmaceutically acceptable fo... Invention Formulations of a csf-1r inhibitor. Described herein, in part, are pharmaceutically acceptable f... Invention Formulations of vimseltinib. Described herein, in part, are pharmaceutically acceptable formulat... Invention Solid forms of an ulk inhibitor. Described herein, in part, are solid-state forms of the compoun... Invention Formulations of vimseltinib Invention Methods of treating tenosynovial giant cell tumors Invention Methods of treating tenosynovial giant cell tumors. inter aliainter alia, methods of treating a t... P/S Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in... P/S Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), gia... Invention Combination therapy for the treatment of mastocytosis. The present disclosure relates to the use... Invention Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-... Invention Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof. Described herein ar... Invention Dual raf and tubulin inhibitors and methods of use thereof Invention Gcn2 and perk kinase modulators and methods of use thereof Invention Gcn2 and perk kinase modulators and methods of use thereof. Described herein are compounds of for... Invention Combination therapy for the treatment of gastrointestinal stromal tumors. The present disclosure ... 2023 P/S pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, sys... P/S Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, sys... 2022 Invention Combination therapy using vps34 inhibitors. Described herein, in part, are methods of treating c... 2021 P/S Business administration of patient reimbursement programs; business administration of medication ... P/S pharmaceutical research and development providing medical information to patients relating to the... 2019 P/S Pharmaceutical oncology treatments, namely treatments for gastrointestinal stromal tumors, system... P/S Pharmaceutical oncology treatments, namely preparations for treating gastrointestinal stromal tum... 2017 Invention Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophe...